CSIMarket
 
National Research Corporation  (NRC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $39.7700 $0.07 0.176%
Day's High: $40.445 Week Perf: -0.8 %
Day's Low: $ 39.50 30 Day Perf: 0.99 %
Volume (M): 48 52 Wk High: $ 47.25
Volume (M$): $ 1,889 52 Wk Avg: $42.42
Open: $39.61 52 Wk Low: $36.21



 Market Capitalization (Millions $) 985
 Shares Outstanding (Millions) 25
 Employees -
 Revenues (TTM) (Millions $) 149
 Net Income (TTM) (Millions $) 31
 Cash Flow (TTM) (Millions $) -18
 Capital Exp. (TTM) (Millions $) 16

National Research Corporation
The National Research Corporation (NRC) is a healthcare performance improvement company headquartered in Lincoln, Nebraska, United States. The company was founded in 1981 by Michael Hays and Richard L. Bjorklund, with the aim of providing healthcare organizations with valuable data and insights to improve quality of care, patient experience, and financial performance. The company's mission is to enable healthcare organizations to provide better patient-centered care and improve their overall performance through an extensive suite of performance improvement solutions.

The NRC has established itself as a leading provider of healthcare performance measurement, analytics, and improvement solutions. The company's services cover all aspects of the healthcare industry, including hospitals, long-term care settings, home health and hospice, and ambulatory care facilities. It provides a range of products and services such as quality measurement surveys, patient experience surveys, market insights and patient satisfaction assessments, workforce engagement tools, care transitions solutions, and an online rating and review platform.

The NRC's quality measurement surveys are designed to help organizations assess their clinical and operational performance across various domains, including patient safety, clinical outcomes, care coordination, and patient experience. The patient experience surveys provided by the NRC are aimed at gathering feedback from patients regarding their care experiences and interactions with healthcare providers, and these surveys are widely used by hospitals and other healthcare facilities to improve communication, care coordination, and patient satisfaction.

In addition, the NRC provides market insights and patient satisfaction assessments to help healthcare organizations identify opportunities for growth and service expansion. The company's workforce engagement tools help healthcare organizations improve staff morale and retain their top-performing employees through insights and analytics on employee satisfaction and engagement. The care transitions solutions provided by the NRC help healthcare organizations improve the safety and effectiveness of care transitions for patients moving between care settings, minimizing the risk of adverse events.

Furthermore, the NRC has an online rating and review platform e MyExperience.com e that allows patients to rate and review healthcare facilities, thus providing healthcare organizations with valuable insight into the needs and preferences of patients in their communities. The platform also allows healthcare organizations to respond to patient feedback, improving transparency, and communication with patients.

Overall, the National Research Corporation is dedicated to providing healthcare organizations with the information they need to improve the quality of care they provide, enhance the patient experience, and improve financial performance. Through a range of products and services, the NRC empowers healthcare organizations to provide better patient-centered care, resulting in improved health outcomes and better overall performance.


   Company Address: 1245 Q Street Lincoln 68508 NE
   Company Phone Number: 475-2525   Stock Exchange / Ticker: NASDAQ NRC
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



National Research Corporation

Breaking Down the Financial Success of NRC Health: A Look at Revenue Consolidation and Earnings Growth in Q4 2023



National Research Corporation (NRC Health) recently released its financial results for the fourth quarter and full calendar year of 2023. Despite a decrease in revenue, the company managed to increase its earnings per share (EPS) and net profits. The CEO, Michael Hays, expressed satisfaction with the company's growth in new sales and operating margin. Additionally, the company achieved a new high in its dividend payout ratio during the third quarter of 2023.
Financial Facts:
1. EPS Growth: NRC Health experienced a 34.48% increase in profit per share, reaching $0.36 per share in the most recent fiscal period. This compares to $0.32 per share in the previous reporting period.
2. Revenue Decline: The company's revenue decreased by -0.375% year on year, amounting to $38.00 million in the most recent fiscal period. However, this decline was marginal, as revenue had increased by 0.148% from $37.95 million in the previous reporting period.
3. Net Earnings Growth: NRC Health reported net earnings of $8.858 million in the most recent fiscal period, reflecting a 33.38% increase from $6.641 million reported in the same period a year ago.

Dividend

National Research Corporation Reports Strong Growth in Fourth Quarter and Sets New Records in Dividend Payout Ratio

Published Tue, Feb 13 2024 10:00 PM UTC



National Research Corporation (NRC Health) announced its fourth-quarter and calendar year 2023 results, showcasing another consecutive quarter of growth in new sales and operating margin. The company's CEO, Michael Hays, expressed satisfaction with the momentum and highlighted the strategic trimming of non-core service lines while enhancing capabilities across the ...

Management Changes

National Research Corporation Elevates Leadership Team to Drive Growth Opportunity

Published Wed, Jan 17 2024 8:00 PM UTC



LINCOLN, Neb. - National Research Corporation, also known as NRC Health (NASDAQ: NRC), has recently made significant leadership changes by creating four executive officer positions. These developments come as the company aims to capitalize on growth opportunities in the market.
Helen Hrdy, an esteemed leader at NRC Health, has been promoted to the crucial role...

National Research Corporation

NRC experiences significant revenue growth in Q3 2023, setting new industry standards

National Research Corporation, dba NRC Health, recently announced its financial results for the third quarter of 2023. Despite a slight elevation in revenue of 0.674%, the company experienced a decline in income of -3.03% compared to the same reporting period a year earlier. However, it is important to note that the company's revenue stood at an impressive $37.95 million, accompanied by an EPS of $0.32.
In comparison to the Medical Laboratories sector, NRC's revenue growth fell short by 3.35% during the same period. This may not be ideal, but it is worth mentioning that the company managed to grow its EPS by 10.34% from the previous reporting period. Additionally, the revenue also witnessed a healthy rise of 4.933% from $36.16 million.

National Research Corporation

National Research Corporation Surprises with an Unexpected 3.03% Revenue Dip between April and June 2023



National Research Corporation recently released its financial results for the April to June 30, 2023 financial period, reflecting a decline in both income and revenue compared to the previous year. This article aims to interpret the key facts from these results, contextualize the performance within the Medical Laboratories industry, and examine other relevant market trends.
1. Revenue and Income:
- Revenue decreased by 3.033% to $36.16 million in Q2 2023, compared to the same period last year.
- Income fell by 12.12% to $0.29 per share, reflecting a decline in profitability.






 

National Research's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
National Research does not provide revenue guidance.

Earnings Outlook
National Research Corporation does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com